amlodipine has been researched along with Hypertension, Renal in 36 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study compared cilnidipine and amlodipine with respect to their effects on renal function and proteinuria." | 9.11 | Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases. ( Kojima, S; Shida, M; Yokoyama, H, 2004) |
| " Therefore, we investigated the beneficial effects of cilnidipine on renal injury in Dahl salt-sensitive (Dahl S) rats fed a high-sucrose diet (HSD), which mimics metabolic syndrome, and compared them with the effects of an L-type CCB, amlodipine." | 7.73 | The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome. ( Enomoto, A; Konda, T; Matsushita, J; Moriyama, T; Takahara, A, 2005) |
| "To determine whether amlodipine besylate decreases systemic arterial blood pressure (BP) and reduces the prevalence of complications in cats with induced hypertensive renal insufficiency." | 7.71 | Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency. ( Brown, CA; Brown, SA; Cartier, LM; Elliot, J; Mathur, S; Moore, PA; Munday, JS; Newell, MA; Sheldon, SE; Syme, H, 2002) |
| "Amlodipine was an effective once daily antihypertensive agent with an acceptable safety profile." | 6.69 | Efficacy of amlodipine in pediatric patients with hypertension. ( Hayes, JR; Mahan, JD; Mentser, MI; Nahata, MC; Tallian, KB; Turman, MA, 1999) |
| " In 11 patients concomitantly treated with cyclosporine the dosage and the trough-level of this agent were stable throughout the trial." | 5.31 | Antihypertensive efficacy of amlodipine in children with chronic kidney diseases. ( Bianchetti, MG; Bianda, ND; Casaulta Aebischer, C; Franscini, LM; Pfister, R; von Vigier, RO, 2001) |
| " This study compared cilnidipine and amlodipine with respect to their effects on renal function and proteinuria." | 5.11 | Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases. ( Kojima, S; Shida, M; Yokoyama, H, 2004) |
| "An interim analysis of the AASK trial at three years demonstrates a renoprotective effect [slower decline in glomerular filtration rate (GFR), delayed onset of significant decrease in GFR, end-stage renal disease (ESRD) or death, and a decrease in urinary protein excretion] of the angiotensin converting enzyme (ACE) inhibitor, ramipril, as compared to the dihydropyridine calcium channel blocker (DHP-CCB), amlodipine, in patients with mild-to-moderate renal insufficiency." | 5.10 | ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial. ( Agodoa, L; Douglas, JG, 2003) |
| "Effects of losartan and amlodipine on blood pressure and albuminuria were compared in a randomized, double-blind, parallel trial involving 48 patients with essential hypertension (sitting diastolic blood pressure between 95 to 115 mm Hg) and impaired renal function (creatinine clearance of 30 to 60 ml/min/1." | 5.08 | Comparison of losartan and amlodipine in renally impaired hypertensive patients. ( Aranda, P; Casado, S; Fernández-Andrade, C; Guerra, L; Iversen, B; Russo, D; Zucchelli, P, 1998) |
| " Therefore, we investigated the beneficial effects of cilnidipine on renal injury in Dahl salt-sensitive (Dahl S) rats fed a high-sucrose diet (HSD), which mimics metabolic syndrome, and compared them with the effects of an L-type CCB, amlodipine." | 3.73 | The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome. ( Enomoto, A; Konda, T; Matsushita, J; Moriyama, T; Takahara, A, 2005) |
| "To determine whether amlodipine besylate decreases systemic arterial blood pressure (BP) and reduces the prevalence of complications in cats with induced hypertensive renal insufficiency." | 3.71 | Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency. ( Brown, CA; Brown, SA; Cartier, LM; Elliot, J; Mathur, S; Moore, PA; Munday, JS; Newell, MA; Sheldon, SE; Syme, H, 2002) |
| "Treatment with indapamide was followed by a significant decrease of plasma adiponectin concentration." | 2.73 | Indapamide decreases plasma adiponectin concentration in patients with essential hypertension. ( Adamczak, M; Chudek, J; Piecha, G; Wiecek, A, 2007) |
| "Patients with end-stage renal disease (ESRD) receiving hemodialysis (HD) treatment have a markedly shortened life expectancy in large part owing to cardiovascular disease (CVD), not explained by established risk factors." | 2.72 | Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. ( Aslam, S; Leone, A; Santha, T; Wilcox, C, 2006) |
| "Losartan was administered once daily at doses of 25 to 100 mg/day, and amlodipine was given once daily at 2." | 2.71 | Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for ( Hayashi, M; Ideura, T; Iino, Y; Kawaguchi, Y; Kawamura, T; Kitajima, T; Koyama, A; Kuwahara, M; Shiigai, T; Sugisaki, T; Suzuki, H; Tomino, Y; Uchida, S; Umemura, S; Yamada, K; Yamazaki, T, 2003) |
| " No patient required discontinuation of amlodipine because of adverse effects." | 2.71 | Efficacy and safety of prolonged amlodipine treatment in hypertensive children. ( Flynn, JT, 2005) |
| "Renal artery stenosis is among the most common curable causes of hypertension." | 2.70 | Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens. ( Deinum, J; Derkx, FH; Krijnen, P; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ, 2001) |
| "Amlodipine was an effective once daily antihypertensive agent with an acceptable safety profile." | 2.69 | Efficacy of amlodipine in pediatric patients with hypertension. ( Hayes, JR; Mahan, JD; Mentser, MI; Nahata, MC; Tallian, KB; Turman, MA, 1999) |
| "Ramipril treatment was associated with a significantly lower risk of DM in African Americans with hypertensive kidney disease than amlodipine or metoprolol treatment." | 1.33 | Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. ( Agodoa, LY; Appel, LJ; Cheek, D; Contreras, G; Gassman, J; Lash, JP; Miller, ER; Randall, OS; Thornley-Brown, D; Wang, X; Wright, JT, 2006) |
| "Proteinuria was reduced with both drugs." | 1.31 | Influence of the timing of initiating antihypertensive therapy in hypertensive rats with renal failure. ( Kanno, Y; Okada, H; Saruta, T; Suzuki, H; Takenaka, T, 2000) |
| " In 11 patients concomitantly treated with cyclosporine the dosage and the trough-level of this agent were stable throughout the trial." | 1.31 | Antihypertensive efficacy of amlodipine in children with chronic kidney diseases. ( Bianchetti, MG; Bianda, ND; Casaulta Aebischer, C; Franscini, LM; Pfister, R; von Vigier, RO, 2001) |
| "2 mg/kg/day for 20 days) chronically receiving AML, there was an enhancement of the antihypertensive effect of AML within a few days after starting chronic dosing, and thereafter a significant reduction of BP at 24 hr after dosing and constant effects of AML during subsequent treatment." | 1.28 | [Antihypertensive effects of amlodipine, a new calcium antagonist]. ( Ishiko, J; Munehasu, S; Suzuki, M; Yamanaka, K, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (22.22) | 18.2507 |
| 2000's | 23 (63.89) | 29.6817 |
| 2010's | 5 (13.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iskenderov, BG | 1 |
| Budagovskaya, ZM | 1 |
| Sisina, ON | 1 |
| Uchida, S | 4 |
| Takahashi, M | 2 |
| Sugawara, M | 1 |
| Saito, T | 1 |
| Nakai, K | 1 |
| Fujita, M | 1 |
| Mochizuki, K | 1 |
| Shin, I | 1 |
| Morita, T | 1 |
| Hikita, T | 1 |
| Itakura, H | 1 |
| Takahashi, Y | 1 |
| Mizuno, S | 1 |
| Ohno, Y | 1 |
| Ito, K | 1 |
| Ito, T | 1 |
| Soma, M | 1 |
| Hayashi, M | 3 |
| Kawamura, T | 3 |
| Kuwahara, M | 3 |
| Nangaku, M | 1 |
| Iino, Y | 3 |
| Beevers, DG | 1 |
| Maheshwari, MB | 1 |
| Ryan, PG | 1 |
| Moss, MS | 1 |
| Harding, LK | 1 |
| Donner, KM | 1 |
| Hiltunen, TP | 1 |
| Suonsyrjä, T | 1 |
| Hannila-Handelberg, T | 1 |
| Tikkanen, I | 1 |
| Antikainen, M | 1 |
| Hirvonen, A | 1 |
| Kontula, K | 1 |
| Rodríguez-Pérez, JC | 1 |
| García-Bello, MA | 1 |
| Anabitarte-Prieto, A | 1 |
| Companioni, O | 1 |
| Nóvoa-Mogollón, FJ | 1 |
| Suárez-Ortega, S | 1 |
| Plaza-Toledano, C | 1 |
| Rodríguez-Esparragón, F | 1 |
| Takagi, H | 1 |
| Mizuno, Y | 1 |
| Yamamoto, H | 1 |
| Goto, SN | 1 |
| Umemoto, T | 1 |
| Rahman, M | 1 |
| Douglas, JG | 1 |
| Agodoa, L | 1 |
| Shiigai, T | 2 |
| Tomino, Y | 2 |
| Yamada, K | 2 |
| Kitajima, T | 2 |
| Ideura, T | 3 |
| Koyama, A | 2 |
| Sugisaki, T | 2 |
| Suzuki, H | 3 |
| Umemura, S | 2 |
| Kawaguchi, Y | 1 |
| Yamazaki, T | 2 |
| Kawaguchii, Y | 1 |
| Kojima, S | 1 |
| Shida, M | 1 |
| Yokoyama, H | 1 |
| Mathur, S | 2 |
| Brown, CA | 2 |
| Dietrich, UM | 1 |
| Munday, JS | 2 |
| Newell, MA | 2 |
| Sheldon, SE | 2 |
| Cartier, LM | 2 |
| Brown, SA | 2 |
| Flynn, JT | 1 |
| Konda, T | 1 |
| Enomoto, A | 1 |
| Matsushita, J | 1 |
| Takahara, A | 1 |
| Moriyama, T | 1 |
| Ishimitsu, T | 1 |
| Kobayashi, T | 1 |
| Honda, T | 1 |
| Minami, J | 1 |
| Ohta, S | 1 |
| Inada, H | 1 |
| Yoshii, M | 1 |
| Ono, H | 1 |
| Matsuoka, H | 1 |
| Thornley-Brown, D | 1 |
| Wang, X | 1 |
| Wright, JT | 2 |
| Randall, OS | 2 |
| Miller, ER | 1 |
| Lash, JP | 1 |
| Gassman, J | 1 |
| Contreras, G | 1 |
| Appel, LJ | 1 |
| Agodoa, LY | 2 |
| Cheek, D | 1 |
| Aslam, S | 1 |
| Santha, T | 1 |
| Leone, A | 1 |
| Wilcox, C | 1 |
| Czupryniak, L | 1 |
| Pawłowski, M | 1 |
| Saryusz-Wolska, M | 1 |
| Loba, J | 1 |
| Piecha, G | 1 |
| Adamczak, M | 1 |
| Chudek, J | 1 |
| Wiecek, A | 1 |
| Fujita, T | 2 |
| Ando, K | 1 |
| Nishimura, H | 1 |
| Yasuda, G | 1 |
| Isshiki, M | 1 |
| Takahashi, K | 1 |
| Dworkin, LD | 1 |
| Tolbert, E | 1 |
| Recht, PA | 1 |
| Hersch, JC | 1 |
| Feiner, H | 1 |
| Levin, RI | 1 |
| Kusek, JW | 2 |
| Toto, RD | 1 |
| Lee, JY | 2 |
| Kirk, KA | 1 |
| Glassock, R | 1 |
| Smith, DE | 1 |
| Milligan, S | 1 |
| Faulkner, M | 1 |
| Cornell, CE | 1 |
| Kopple, JD | 1 |
| Greene, PG | 1 |
| Passavanti, G | 1 |
| Vernaglione, L | 1 |
| Mancini, A | 1 |
| Fernández-Andrade, C | 1 |
| Russo, D | 1 |
| Iversen, B | 1 |
| Zucchelli, P | 1 |
| Aranda, P | 1 |
| Guerra, L | 1 |
| Casado, S | 1 |
| Tallian, KB | 1 |
| Nahata, MC | 1 |
| Turman, MA | 1 |
| Mahan, JD | 1 |
| Hayes, JR | 1 |
| Mentser, MI | 1 |
| Usalan, C | 1 |
| Erdem, Y | 1 |
| Arici, M | 1 |
| Altun, B | 1 |
| Shigihara, T | 1 |
| Sato, A | 1 |
| Hayashi, K | 1 |
| Saruta, T | 2 |
| Kanno, Y | 1 |
| Okada, H | 1 |
| Takenaka, T | 1 |
| Satomura, A | 1 |
| Hidaka, M | 1 |
| Ohsawa, I | 1 |
| Endo, M | 1 |
| Ohi, H | 1 |
| von Vigier, RO | 1 |
| Franscini, LM | 1 |
| Bianda, ND | 1 |
| Pfister, R | 1 |
| Casaulta Aebischer, C | 1 |
| Bianchetti, MG | 1 |
| van Jaarsveld, BC | 1 |
| Krijnen, P | 1 |
| Derkx, FH | 1 |
| Deinum, J | 1 |
| Woittiez, AJ | 1 |
| Postma, CT | 1 |
| Schalekamp, MA | 1 |
| McConaghy, JR | 1 |
| Syme, H | 1 |
| Elliot, J | 1 |
| Moore, PA | 1 |
| Yamanaka, K | 1 |
| Suzuki, M | 1 |
| Munehasu, S | 1 |
| Ishiko, J | 1 |
1 review available for amlodipine and Hypertension, Renal
| Article | Year |
|---|---|
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calc | 2013 |
23 trials available for amlodipine and Hypertension, Renal
| Article | Year |
|---|---|
[Effect of a fixed-dose perindopril and amlodipine combination on intrarenal hemodynamic and kidney functional parameters in patients with essential hypertension].
Topics: Adult; Amlodipine; Antihypertensive Agents; Drug Combinations; Female; Glomerular Filtration Rate; H | 2013 |
Effects of the N/L-type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients with chronic kidney disease (J-CIRCLE study).
Topics: Aged; Aged, 80 and over; Albuminuria; Amlodipine; Blood Pressure; Calcium Channel Blockers; Creatini | 2014 |
Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhi | 2015 |
CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Bisoprolol; | 2009 |
Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; An | 2011 |
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Black or African | 2003 |
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for
Topics: Adult; Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; | 2003 |
Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension--a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Female; Humans; Hypertension, Renal; Japan; Kidney Failur | 2004 |
Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.
Topics: Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, N-Type; Creatinine; Dihydropyridines; | 2004 |
Efficacy and safety of prolonged amlodipine treatment in hypertensive children.
Topics: Adolescent; Amlodipine; Blood Pressure; Calcium Channel Blockers; Child; Child, Preschool; Female; H | 2005 |
Protective effects of an angiotensin II receptor blocker and a long-acting calcium channel blocker against cardiovascular organ injuries in hypertensive patients.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphe | 2005 |
Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Arginine; Blood | 2006 |
Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Circadian Rhythm; Diab | 2007 |
Indapamide decreases plasma adiponectin concentration in patients with essential hypertension.
Topics: Adiponectin; Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Enalapril; Female; Glomerul | 2007 |
Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; | 2007 |
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black or African American; Blood Pressur | 1996 |
Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Atenolol; Black or African A | 1996 |
Comparison of losartan and amlodipine in renally impaired hypertensive patients.
Topics: Adult; Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium; Creatine; Fe | 1998 |
Efficacy of amlodipine in pediatric patients with hypertension.
Topics: Administration, Oral; Adolescent; Amlodipine; Antihypertensive Agents; Blood Pressure; Child; Female | 1999 |
Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Cha | 2000 |
Angiotensin-converting enzyme inhibitors improve nephrosis more quickly than calcium antagonists in diabetic patients.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blocker | 2000 |
Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cohort Studi | 2001 |
What is the best treatment for slowing the progression to end-stage renal disease (ESRD) in African Americans with hypertensive nephropathy?
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Black People; Double-Blind Method; Female; Glomeru | 2001 |
12 other studies available for amlodipine and Hypertension, Renal
| Article | Year |
|---|---|
Hypertension due to a renin-secreting juxtaglomerular cell tumor.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Biomarkers; Humans; Hyperaldosteronism; Hyp | 2008 |
Initial findings of the AASK: African Americans with hypertensive kidney disease benefit from an ACE inhibitor.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African Amer | 2003 |
Evaluation of a technique of inducing hypertensive renal insufficiency in cats.
Topics: Amlodipine; Analysis of Variance; Animals; Blood Pressure; Blood Pressure Determination; Cat Disease | 2004 |
The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome.
Topics: Amlodipine; Animals; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Ca | 2005 |
Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Antihypertensive Agents; Black or African American; | 2006 |
Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension.
Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Desoxycorticosterone; Glo | 1996 |
Effects of amlodipine and enalapril alone and in combination on glomerular hemodynamics in a hypertensive patient with unilaterally contracted kidney.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Interacti | 1998 |
Severe thrombocytopenia associated with amlodipine treatment.
Topics: Adult; Amlodipine; Antihypertensive Agents; Female; Humans; Hypertension, Renal; Kidney Failure, Chr | 1999 |
Influence of the timing of initiating antihypertensive therapy in hypertensive rats with renal failure.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressu | 2000 |
Antihypertensive efficacy of amlodipine in children with chronic kidney diseases.
Topics: Adolescent; Adult; Age Factors; Amlodipine; Antihypertensive Agents; Blood Pressure; Child; Child We | 2001 |
Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency.
Topics: Albuminuria; Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Cat Diseases; Cats; Fema | 2002 |
[Antihypertensive effects of amlodipine, a new calcium antagonist].
Topics: Administration, Oral; Amlodipine; Animals; Calcium Channel Blockers; Dogs; Dose-Response Relationshi | 1991 |